By Charlie Smith

Havn Life Sciences Ivan Casselman Casselman

Havn Life Sciences chief psychedelic officer marries love of plants with desire to help

Dr. Ivan Casselman says he has been setting himself up to work in the psychedelic industry for quite some time.

Kamala Kamala Harris market cap billion

Market cap madness—cannabis investors enjoy the highs after Kamala Harris promises decriminalization

The Democratic vice presidential nominee has shown that her words can move markets.

investors cannabis investors stock price

Up in Smoke best describes what happened to cannabis investors this week

Aurora Cannabis shares have been pummelled since the start of the year; over the same period, Tilray stock has fared nearly as badly.

Aurora Cannabis Aurora Aurora shares weed company

Aurora Cannabis shares plunge by 29 percent; other weed stocks also decline

Canopy Growth Corp. is now worth nine times as much as the Edmonton-based weed company.

Havn Life psychedelics company

Vancouver psychedelics company Havn Life obtains Health Canada exemption

Health Minister Patty Hajdu has given its wholly owned subsidiary the green light to possess pure psilocybin for research purposes.

cannabis market top three three picks

Predicting stocks in the cannabis market isn’t as easy as it might seem to be

For a trio of online sources, their top three investment picks for the month failed to deliver dazzling results in the first week of September.